Miyagi, Japan

Hirofumi Ueda

This inventor holds 1 USPTO granted patent. Top assignee: Tohoku University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirofumi Ueda. Retrieved from https://idiyas.com/inventor/hirofumi-ueda-xhwotctz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirofumi Ueda: Innovator in Pulmonary Hypertension Treatment

Introduction

Hirofumi Ueda is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. His innovative approach has led to the development of a unique therapeutic agent that addresses this serious health condition.

Latest Patents

Hirofumi Ueda holds a patent for a pulmonary hypertension preventative or therapeutic agent containing a crude drug. The invention aims to provide a novel preventive or therapeutic agent for pulmonary hypertension, utilizing emetine or a salt thereof as the active ingredient. This compound has not been previously recognized for its therapeutic effects on pulmonary hypertension, marking a significant advancement in treatment options.

Career Highlights

Ueda is affiliated with Tohoku University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential to improve patient outcomes in pulmonary hypertension.

Collaborations

Hirofumi Ueda has collaborated with esteemed colleagues, including Hiroaki Shimokawa and Hidetoshi Tokuyama. Their combined expertise has contributed to the advancement of research in pulmonary hypertension and related therapeutic strategies.

Conclusion

Hirofumi Ueda's contributions to the field of pulmonary hypertension treatment exemplify the impact of innovative research in medicine. His patent for a novel therapeutic agent represents a promising development for patients suffering from this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…